Glaxo Defends Flonase From Generics With Manufacturing Spec Petition
This article was originally published in The Tan Sheet
Executive Summary
GlaxoSmithKline is attempting to impede generic competition for itsFlonase nasal steroid with the filing of the second citizen petition this year related to the product
You may also be interested in...
Flonase Generic Launch Blocked; Glaxo Drops Switch Plan
GlaxoSmithKline has shelved an OTC switch of Flonase nasal steroid as a competitive strategy in favor of litigation to block generics
Flonase Generic Launch Blocked; Glaxo Drops Switch Plan
GlaxoSmithKline has shelved an OTC switch of Flonase nasal steroid as a competitive strategy in favor of litigation to block generics
Flonase Generic Launch Blocked; Glaxo Drops Switch Plan
GlaxoSmithKline has shelved an OTC switch of Flonase nasal steroid as a competitive strategy in favor of litigation to block generics